Symptom improvement from prokinetic therapy corresponds to improved quality of life in patients with severe dyspepsia

Digestive Diseases and Sciences

Volumn 41, Issue 7, 1996, Pages 1369-1378

  Cutts, Teresa F ^a   Abell, Thomas L ^a   Karas, James G ^a   Kuns, Judy ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

cisapride; domperidone; dyspepsia; prokinetic drugs; quality of life

Indexed keywords

CISAPRIDE; DOMPERIDONE; PROKINETIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; DYSPEPSIA; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE;

ADULT; AGED; ATTITUDE TO HEALTH; CISAPRIDE; DOMPERIDONE; DYSPEPSIA; FEMALE; GASTROINTESTINAL AGENTS; GASTROINTESTINAL MOTILITY; HUMANS; MALE; MIDDLE AGED; MMPI; PERSONALITY INVENTORY; PIPERIDINES; PROSPECTIVE STUDIES; QUALITY OF LIFE;

EID: 0030035884     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02088561     Document Type: Article

References (44)

1. Ware JE, Broom RH, Davis AR, Loht KW: Choosing measures of health status for individuals in general populations. Am J Public Health 71:620-625, 1981
2. Spitzer WO, Dobson AJ, Hall J, et al: Measuring the quality of life of cancer patients. J Chron Dis 34:585-597, 1981
3. Evans RW, Manninen DL, Garrison LP, et al: Quality of life of patients with end stage renal disease. N Engl J Med 312:553-559, 1985
4. Liang MH, Larson MG, Cullen KE, Schwartz JA: Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. Arthritis Rheum 28:542-547, 1985
5. Rudick RA, Miller D, Clough JD, Gragg LA, Farmer RG: Quality of life in multiple sclerosis. Comparison with inflammatory bowel disease and rheumatoid arthritis. Arch Neurol 49:1237-1242, 1992
6. Stewart AL, Greenfield S, Hays RD, Wells K, Rogers WH, Berry SD, McGlynn EA, Ware JE: Functional status and well-being of patients with chronic conditions. Results from the medical outcomes study. JAMA 262:907-913, 1989
7. Irvine EJ: A quality of life index for inflammatory bowel disease. Can J Gastroenterol 7(2):155-159, 1993
8. Farmer RG, Easley KA, Farmer JM: Quality of life assessment by patients with inflammatory bowel disease. Cleve Clin J Med 1992;59:35-42
9. Guyatt G, Mitchell A, Irvine EJ, Singer J, Williams N, Goodacre R, Tompkins C. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 96:804-810, 1989
10. Moody GA, Mayberry JF: Quality of life: Its assessment in gastroenterology. Eur J Gastroenterol Hepatol 4:1025-1030, 1992
11. Zbrozek A, Hoop R, Robinson M, McPherson M: Test of an instrument to measure function-related quality of life in patients with ulcerative colitis. PharmacoEconomics 4(1):31-39, 1993
12. Heymen S, Wexner SD, Gulledge AD: MMPI assessment of patients with functional bowel disorders. Dis Colon Rectum 36:593-596, 1993
13. Richter JE, Obrecht WF, Bradley LA, Yound LD, Anderson KO: Psychological comparison of patients with nutcracker esophagus and irritable bowel syndrome. Dig Dis Sci 31:131-138, 1986
14. Abell TL, Cutts TF, Cooper T: Effect of cisapride therapy for severe dyspepsia on gastrointestinal symptoms and quality of life. Scand J Gastroenterol 28(suppl 195):60-64, 1993
15. Cooper T, Cutts TF, Abell TL, West L, Cardoso S: Long-term cisapride therapy improves quality of life measures in patients with symptoms of gastroparesis. Gastroenterology 100(part 2):A432, 1991
16. Corinaldesi R, Stanghellini V, Raiti C, Rea A, Salgemini R, Barbara L: Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis. Gut 28:300-305, 1987
17. Abell TL, Camilleri M, DiMagno EP, Hench VS, Zinsmeister AR, Malagelada J-R: Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility. Dig Dis Sci 36:616-620, 1991
18. Camilleri M, Malagelada J-R, Abell TL, Brown MC, Hench V, Zinsmeister AR: Effect of six weeks' treatment with cisapride in gastroparesis and intestinal pseudo-obstruction. Gastroenterology 96:704-712, 1989
19. McCallum RW, Petersen J, Dubovic S: Effects of cisapride on gastric emptying and symptoms associated with gastroparesis. Gastroenterology 90:1541, 1986
20. Maddern GJ, Jameison GG, Myers JC, Collins PJ: Effect of cisapride on delayed gastric emptying in gastro-oesophageal reflux disease. Gut 32:470-474, 1991
21. Baldi F, Bianchi PG, Dobrilla G, et al: Cisapride versus placebo in reflux esophagitis. A multicenter double-blind trial. J Clin Gastroenterol 10:614-618, 1988
22. Valenzuela G, Fisher K, Davenport K, Plankey M, McCallum RW: Long term subjective and objective effects of cisapride in the treatment of gastroparesis. Gastroenterology 98:A399, 1990
23. Fumagalli I, Hammer B: Cisapride versus metoclopramide in the treatment of functional dyspepsia. A double-blind comparative trial. Scand J Gastroenterol 29:33-37, 1994
24. Horowitz M, Harding PE, Chatterton BE, Collins PJ, Shearman DJ: Acute and chronic effects of domperidone on gastric emptying in diabetic autonomic neuropathy. Dig Dis Sci 30:1-9, 1985
25. Champion MC, Gulenchyn K, O'Leary T, Irvine P, Edwards A, Braaten J, Gay J: Domperidone (Motilium) improves symptoms and solid phase gastric emptying in diabetic gastroparesis. Am J Gastroenterol 82:975, 1987
26. Heer M, Muller-Duysing W, Benes I, Weitzel M, Pirovino M, Altorfer J, Schmid M: Diabetic gastroparesis: Treatment with domperidone - a double-blind, placebo-controlled trial. Digestion 27:214-217, 1983
27. Patterson DJ, Botoman VA, Kozarek RA, Skinner SM: Domperidone is effective long-term treatment for diabetic gastroparesis. Gastroenterology 100(suppl):A137, 1991
28. Koch KI, Stern RM, Stewart WR, Vasey MW: Gastric emptying and gastric myoelectrical activity in patients with diabetic gastroparesis: Effect of long-term domperidone treatment. Am J Gastroenterol 84:1069-1075, 1989
29. Kozarek R: Domperidone for symptomatic management of diabetic gastroparesis in metoclopramide treatment failures. Adv Ther 7:61-68, 1990
30. Gordon SJ, Joseph RE: Clinical evaluation of a dopamine receptor inhibitor, domperidone in patients with gastroesophageal reflux, gastritis and gastroparesis. Gastroenterology 78:1174, 1980
31. Abell TL, Murphy W, Schwartzbaum J, Familoni B, Wilson R, Cardoso S, Massie D: The role of the MMPI in the evaluation of patients with symptoms of upper gut dysmotility. Gastroenterology 94(5):A2, 1988
32. Drossman DA, et al: Identification of subgroups of functional gastrointestinal disorders. Gastroenterol Int 3:159-172, 1990
33. Schneider JH, Sternthal MB, Lichtiger S, Present DH, Kornbluth A: Cyclosporine therapy in patients with severe ulcerative colitis: A quality of life assessment. Am J Gastroenterol 86:1361, 1991
34. Swenson WM, Pearson JS, Osborne D: An MMPI Source Book: Basic Item, Scale and Pattern Data on 50,000 Medical Patients. Minneapolis, University of Minnesota Press, 1973
35. Millon T, Green CJ, Meagher RB: Millon Behavioral Health Inventory Manual, 3rd ed. Minneapolis, National Computer Systems, 1982
36. Bergner M, Bobbitt RA, Carter WF, Gilson BS: The sickness impact profile: Development and final revision of a health status measure. Med Care 19:787-805, 1981
37. Drossman DA, Patrick DL, Mitchell CM, Zagami EA, Appelbaum MI: Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns. Dig Dis Sci 34(9):1379-1386, 1989
38. Cutts TF, Abell TL, Aggarwal A, Cardoso S, Murphy W: Correlation of MMPI scales and autonomic function tests in patients with symptoms of gastroparesis. Presented at the Society of Behavioral Medicine Meeting, San Francisco, 1989
39. Drossman DA, McKee DC, Sandler RS, Mitchell CM, Cramer EM, Lowman BC, Burger AL: Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and non-patients with irritable bowel syndrome. Gastroenterology 95:701-708, 1988
40. Whitehead WE, Bosmajian L, Zonderman AB, Costa PT, Schuster MM: Symptoms of psychologic distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples. Gastroenterology 95:709-714, 1988
41. Cutts TF, Abell TL, Aggarwal A, Cardoso S: Gastric emptying, psychological profiles, and autonomic function in diabetic gastroparesis. Gastroenterology 92(part 2):A342, 1990
42. Kunsebeck HW, Korber J, Freyberger H: Quality of life in patients with inflammatory bowel disease. Psychother Psychosom 51:110-116, 1990
43. Gill TM, Feinstein AR: A critical appraisal of the quality of quality-of-life measurements. JAMA 272:619-626, 1994
44. Cutts TF, Abell TL: Quality of life measures in gastroenterology. Motility 26:4-7, 1994